These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15573085)

  • 1. Who will regulate the regulators?
    Goldman JM
    Bone Marrow Transplant; 2004 Dec; 34(12):1013-4. PubMed ID: 15573085
    [No Abstract]   [Full Text] [Related]  

  • 2. Just another cost increasing exercise (JACIE)?
    Apperley J
    Bone Marrow Transplant; 2004 Nov; 34(10):835-8. PubMed ID: 15517004
    [No Abstract]   [Full Text] [Related]  

  • 3. JACIE accreditation in Europe moves ahead.
    Kvalheim G; Gratwohl A; Urbano-Ispizua A;
    Cytotherapy; 2003; 5(4):306-8. PubMed ID: 12944236
    [No Abstract]   [Full Text] [Related]  

  • 4. Family donor care management: principles and recommendations.
    van Walraven SM; Nicoloso-de Faveri G; Axdorph-Nygell UA; Douglas KW; Jones DA; Lee SJ; Pulsipher M; Ritchie L; Halter J; Shaw BE;
    Bone Marrow Transplant; 2010 Aug; 45(8):1269-73. PubMed ID: 20023708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor and liability insurance of donor registries, donor centers, and collection centers--recommendations.
    Egeland T; Lie J; Persson U; Raymond J; Müller C;
    Bone Marrow Transplant; 2004 Mar; 33(5):467-70. PubMed ID: 14688817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Marrow Donor Association (WMDA): its goals and activities.
    Gahrton G; van Rood JJ; Oudshoorn M;
    Bone Marrow Transplant; 2003 Jul; 32(2):121-4. PubMed ID: 12838274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).
    Wiegand T; Raffoux C; Hurley CK; Kern M; Oudshoorn M; Raymond J; Cleaver S; Marry E; Muller C; ;
    Bone Marrow Transplant; 2004 Jul; 34(2):97-101. PubMed ID: 15170174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cellular therapies: the Australian perspective.
    Wall DM; Prince HM
    Cytotherapy; 2003; 5(4):284-8. PubMed ID: 12944233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure.
    Chybicka A
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S87-9. PubMed ID: 18978753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical research: the best or worst of times?
    Ferrara JL; Wingard JR
    Biol Blood Marrow Transplant; 2002; 8(6):293-4. PubMed ID: 12108914
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic progenitor cell transplantation in 2007: new challenges and new opportunities for the center for international blood and marrow transplant research.
    Giralt S
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):263-4. PubMed ID: 17317579
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematopoietic stem cell donor selection: the Europdonor experience.
    Oudshoorn M; van Walraven SM; Bakker JN; Lie JL; V D Zanden HG; Heemskerk MB; Claas FH
    Hum Immunol; 2006 Jun; 67(6):405-12. PubMed ID: 16728261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual physician practice variation in hematopoietic cell transplantation.
    Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
    J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint position paper on the regulatory approach to hematopoietic cell components in the United States.
    J Hematother; 1997 Apr; 6(2):91-2. PubMed ID: 9131437
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of identifying a back-up donor for unrelated stem cell transplantation.
    van Walraven SM; Heemskerk MB; Lie JL; Barge RM; Cornelissen JJ; Egeler RM; Verdonck LF; Wulffraat N; Oudshoorn M
    Bone Marrow Transplant; 2005 Mar; 35(5):437-40. PubMed ID: 15640816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demystifying the standards process.
    Moore R
    Med Device Technol; 2003 Nov; 14(9):38. PubMed ID: 14682023
    [No Abstract]   [Full Text] [Related]  

  • 17. The ethics of hematopoietic stem cell donation by minors.
    Ross LF
    Arch Pediatr Adolesc Med; 2009 Nov; 163(11):1065; author reply 1065-6. PubMed ID: 19884600
    [No Abstract]   [Full Text] [Related]  

  • 18. The price of life.
    Malik P
    Can J Cardiol; 2001 Mar; 17(3):267-8. PubMed ID: 11264558
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers call for new, independent federal agency to address health care quality and cost.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Dec; 14(24):7-9. PubMed ID: 14677564
    [No Abstract]   [Full Text] [Related]  

  • 20. The hazards of transplant tourism.
    Delmonico FL
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):249-50. PubMed ID: 19218470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.